FDA inspection

Daiichi Sankyo Propharma Co., Ltd.: FDA inspection ending Jan 22, 2001

FDA inspection 67624 · No Action Indicated (NAI) · Hiratsuka

Key facts

Inspection ID 67624
Firm Daiichi Sankyo Propharma Co., Ltd.
FEI number 3002808070
Address 1 Chome 12-1, Shinomiya
City Hiratsuka
Fiscal year 2001
Inspection end date Jan 22, 2001
Classification No Action Indicated (NAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections